BioAge Labs BIOA
NASDAQ BIOA
$5.58 +0.02 (+0.36%)
As of: Oct 21, 2026 · 1:47 PM EDT

BioAge Labs (BIOA) Receivables (2025 - 2026)

Updated

BioAge Labs' Receivables was $625,000 in Q2 2026, up 3.6% from $603,000 a year earlier but down 11.8% from the prior quarter.

Analysis

BioAge Labs (BIOA) Receivables (2025 - 2026) Analysis & Trends

At the end of FY2025, Receivables at BioAge Labs came in at $769,000.

  • Quarterly Receivables has moved between $361,000 (Q1 2025) and $769,000 (Q4 2025) over five years.
  • Per Business Quant data, BIOA's Receivables in the three quarters before Q2 2026 was $709,000 (Q1 2026), $769,000 (Q4 2025) and $515,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,134.13 Bn 1,102.72 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn 19.05 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn 13.82 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 297.88 Bn 261.87 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.36 Bn 235.05 Bn 12.86 Bn 15.68 Bn
7 Amgen 235.80 Bn 191.20 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 190.78 Bn 164.97 Bn 6.22 Bn 5.06 Bn
9 Pfizer 169.43 Bn 116.08 Bn 10.94 Bn 12.49 Bn
10 BioAge Labs 250.20 Mn -1.55 Bn -14.23 Mn 625,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 625,000.00
Mar 31, 2026 709,000.00
Dec 31, 2025 769,000.00
Sep 30, 2025 515,000.00
Jun 30, 2025 603,000.00
Mar 31, 2025 361,000.00
API Access

BioAge Labs Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=BIOA&period=max&api_key=YOUR_API_KEY